AccuGenomics, Inc

AccuGenomics is a life science tools developer with a disruptive technology to improve the accuracy of sequencing tests (NGS) in precision medicine. Improve diagnostic accuracy and monitor any treatment response (MRD) by addressing inaccurate NGS tests.

AccuGenomics has multiple existing products (Myeloid, CRC/NSCLC, ctDNA MRD, TP53, Breast Cancer) and also provides custom mixtures of internal standards.